Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
British Journal of Cancer|April 14, 2021
Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive frameworkKamal S Saini, Chris TwelvesEuropean Journal of Clinical Investigation|July 6, 2010
Polycythemia vera-associated pruritus and its managementKamal S Saini, Mrinal M Patnaik, Ayalew TefferiEcancermedicalscience|May 2, 2015
Treatment of early-stage HER2+ breast cancer-an evolving fieldArlindo R Ferreira, Kamal S Saini, Otto Metzger-FilhoOncotargets and Therapy|May 10, 2011
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selectionCarmen Criscitiello, Debora Fumagalli, Kamal S Saini, et al.Drug Safety|December 6, 2011
Benefit-risk assessment of bevacizumab in the treatment of breast cancerRodrigo Dienstmann, Felipe Ades, Kamal S Saini, et al.Critical Reviews in Oncology/Hematology|September 7, 2010
Prevention and management of major side effects of targeted agents in breast cancerOtto Metzger Filho, Kamal S Saini, Hatem A Azim, et al.Journal for Immunotherapy of Cancer|January 13, 2022
Immuno-oncology trends: preclinical models, biomarkers, and clinical developmentMaryland Rosenfeld Franklin, Suso Platero, Kamal S Saini, et al.Cancers|March 13, 2024
The Convergence of Radiology and Genomics: Advancing Breast Cancer Diagnosis with RadiogenomicsDemetra Demetriou, Zarina Lockhat, Luke Brzozowski, et al.European Radiology|February 9, 2026
What are RECIST 1.1 progressions made of? Variability in double-read oncology trialsHubert Beaumont, Luca Cantini, Kamal S Saini, et al.Trials|April 4, 2023
Quantifying the impact of the COVID-19 pandemic on clinical trial screening rates over time in 37 countriesKelsey McDonald, Earl Seltzer, Mary Lu, et al.Pageof 6